OBJECTIVES: To assess the implementation of home blood pressure measurement (HBPM) by French general practitioners (GPs) in current practice in 2009 and to assess the evolution of practices between 2004 and 2009; the perceived benefits and limitations of the method; and the adherence to methodological European [European Society of Hypertension (ESH) 2007] or French [La Haute Autorité de Santé (HAS) 2005] recommendations. METHOD: Two phone surveys on a representative random sample of French GPs in 2004 and then in 2009. RESULTS: Five hundred and forty and 801 GPs were contacted in 2004 and 2009, respectively, in which 511 and 500 participated, including the same 214 in both surveys. The proportion of HBPM users increased between 2004 (70%) and 2009 (92%) (P < 0.0001). The majority still remained occasional users (71%), whereas a minority (21%) used this method nearly systematically in 2009. In 2009, both users and nonusers highlighted the lack of reliability of devices (19 and 47%) and lack of patient reliability (27 and 24%) and patient anxiety (47 and 29%). The expected benefit was primarily the detection of white-coat effect (70%), therapeutic adaptation (36%), diagnostic aid (25%), and better compliance with treatment (14%). Masked hypertension detection (2%) and prognostic interest (0.7%) were marginal. The GPs declared rarely adopting ESH methodology (3% of users), but more often HAS methodology (33%). Adherence to the complete methodology was rare (absolute adherence <1%), but more often 'minimal' (three morning and evening measurements, at least 3 days with an upper arm cuff: 17%). Contraindications of HBPM use were not known. CONCLUSION: Despite greater use of HBPM after enactment of the recommendations, the methodology is not strictly implemented, making its diagnostic and prognostic value uncertain.
OBJECTIVES: To assess the implementation of home blood pressure measurement (HBPM) by French general practitioners (GPs) in current practice in 2009 and to assess the evolution of practices between 2004 and 2009; the perceived benefits and limitations of the method; and the adherence to methodological European [European Society of Hypertension (ESH) 2007] or French [La Haute Autorité de Santé (HAS) 2005] recommendations. METHOD: Two phone surveys on a representative random sample of French GPs in 2004 and then in 2009. RESULTS: Five hundred and forty and 801 GPs were contacted in 2004 and 2009, respectively, in which 511 and 500 participated, including the same 214 in both surveys. The proportion of HBPM users increased between 2004 (70%) and 2009 (92%) (P < 0.0001). The majority still remained occasional users (71%), whereas a minority (21%) used this method nearly systematically in 2009. In 2009, both users and nonusers highlighted the lack of reliability of devices (19 and 47%) and lack of patient reliability (27 and 24%) and patientanxiety (47 and 29%). The expected benefit was primarily the detection of white-coat effect (70%), therapeutic adaptation (36%), diagnostic aid (25%), and better compliance with treatment (14%). Masked hypertension detection (2%) and prognostic interest (0.7%) were marginal. The GPs declared rarely adopting ESH methodology (3% of users), but more often HAS methodology (33%). Adherence to the complete methodology was rare (absolute adherence <1%), but more often 'minimal' (three morning and evening measurements, at least 3 days with an upper arm cuff: 17%). Contraindications of HBPM use were not known. CONCLUSION: Despite greater use of HBPM after enactment of the recommendations, the methodology is not strictly implemented, making its diagnostic and prognostic value uncertain.
Authors: Grzegorz Bilo; Oscar Sala; Carlotta Perego; Andrea Faini; Lan Gao; Anna Głuszewska; Juan Eugenio Ochoa; Dario Pellegrini; Laura Maria Lonati; Gianfranco Parati Journal: Hypertens Res Date: 2017-01-12 Impact factor: 3.872